"Designing Growth Strategies is in our DNA"

U.S. Over the Counter Drugs Market Size, Share & COVID-19 Impact Analysis, By Product Type (Analgesics, Cold & Cough Remedies, Digestives & Intestinal Remedies, Skin Treatment, Vitamins & Minerals, and Others), By Distribution Channel (Drug Stores & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI107911

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
    3. Impact of Covid-19 on the Market
  5. U.S. Over The Counter Drugs Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Analgesics
      2. Cold & Cough Remedies   
      3. Digestives & Intestinal Remedies  
      4. Skin Treatment     
      5. Vitamins & Minerals           
      6. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Drug Stores & Retail Pharmacies   
      2. Hospital Pharmacies           
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Johnson & Johnson Services Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Bayer AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Sanofi S.A
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Pfizer
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. GlaxoSmithKline Plc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Boehringer Ingelheim International GmbH
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Reckitt Benckiser Group PLC
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Takeda Pharmaceutical Company Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Perrigo Company plc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. New Product Launches, By Key Players
    2. Recent Industry Developments – Partnerships, Mergers & Acquisitions
    3. Impact of Covid-19 on the Market
  5. U.S. Over The Counter Drugs Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Analgesics
      2. Cold & Cough Remedies   
      3. Digestives & Intestinal Remedies  
      4. Skin Treatment     
      5. Vitamins & Minerals           
      6. Others
    2. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Drug Stores & Retail Pharmacies   
      2. Hospital Pharmacies           
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles (Overview, Product, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
      1. Johnson & Johnson Services Inc.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      2. Bayer AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      3. Novartis AG
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      4. Sanofi S.A
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      5. Pfizer
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      6. GlaxoSmithKline Plc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      7. Boehringer Ingelheim International GmbH
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      8. Reckitt Benckiser Group PLC
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      9. Takeda Pharmaceutical Company Ltd.
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
      10. Perrigo Company plc
        1. Overview,
        2. Product,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. financials (Based on Availability)
Read Less

Figure 1:  U.S. Over The Counter Drugs Market Value Share (%), by Product Type, 2022 & 2030

Figure 2:  U.S. Over The Counter Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 3:  U.S. Over The Counter Drugs Market Share (%), By Company, 2022

Table 1:  U.S. Over The Counter Drugs Market Revenue (USD million) Forecast, by Product Type, 2019-2030

Table 2:  U.S. Over The Counter Drugs Market Revenue (USD million) Forecast, by Distribution Channel, 2019-2030

U.S. Over the Counter Drugs Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 60
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports